Finding the word “dogs” in a peptide paper is a reason to read more closely. It does not, by itself, establish that the material treats a canine condition.
A concrete example
He and colleagues published a 2022 study of BPC-157 pharmacokinetics, distribution, metabolism and excretion in rats and dogs. The canine work included intravenous and intramuscular administration and measured exposure over time. Read the original study for its methods and findings.
That scope matters. Pharmacokinetic work asks how a substance moves through the body. It does not establish that a Canitide formula improves recovery, that combining ingredients is appropriate or that another administration route performs the same way.
Keep three questions on separate lines
- What did this experiment establish about its tested material?
- What evidence would a proposed canine indication still require?
- What would establish the identity, quality and legal marketing status of a specific product?
Those questions help a conversation remain useful when a finding is interesting but incomplete. FDA’s overview of unapproved animal drugs provides separate context on legal marketing status.
Use the checklist
Our evidence-reading checklist is a discussion aid for recording study scope and unanswered questions. It is not a clinical protocol or a scoring system for deciding what to give a dog.
If you work in veterinary medicine or peptide research, we would welcome your perspective on the next question to investigate. See the partnership brief.
Updated 2026-09-25 · Canipep editorial